Habitat for Humanity Canada elects National Board of Directors at its annual general meeting
TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- Habitat for Humanity Canada, the country's only national affordable homeownership organization, announced its National Board of Directors at the charity's annual general meeting on May 16, 2025 in Halifax.
Habitat Canada's National Board of Directors is comprised of 16 volunteers who are dedicated to a vision of a world where everyone has a safe and affordable place to live. They bring a range of skills and experience to the organization in housing, business, law, governance, technology, operations, finance, and risk management. Internal candidates are nominated by Habitat's federation of local organizations.
Many members of the National Board of Directors have also served as a board member of a local Habitat organization, volunteered with Habitat Canada's international volunteer experience, Global Village, or volunteered at Habitat's social enterprise, Habitat ReStore.
The board will guide the organization as it recommits to growing its impact on Canada's housing crisis through its affordable homeownership program, critical repairs to housing, community partnerships, skills training and advocacy.
Director joining for a three-year term:
Jim Garner, nominated by Habitat for Humanity Greater Toronto Area
Jim is a retired senior executive with broad executive leadership and board experience in finance, strategy, health care, life sciences and education. He is currently Chair of ORION, Ontario's research and education network, and a director at Habitat for Humanity Greater Toronto Area (GTA) where he is a member of the Finance, Audit and Risk Management Committee and chairs the Campaign Cabinet. Jim is a CPA/CA and a Chartered Business Valuator and earned his ICD.D designation from the Institute of Corporate Directors. He is a graduate of IMD (MBA) and Queen's University (B. Comm.)
Directors re-elected for a three year-term:
Leland Corbett and David Hooper, nominated by Habitat for Humanity Southern Alberta, Sharon Kuropatwa, Corinna Mitchell-Beaudin and Mehdi Nezarati
Directors continuing an ongoing term:
Seynabou Ba, Kimberley Cook, Kathleen Flynn, Ken Lancaster, Paul Mason, Craig Meeds, Rachel O'Connor, Brad Peters and Riccardo Trecroce
Sidra Anjum, ex-officio member, also joins the board through the Fora Network for Change Rise on Boards program. Rise on Boards trains and places emerging leaders from diverse backgrounds on boards of directors with a goal of increasing gender equity and representation on governance boards across Canada.
Habitat Canada thanks departing member Christine Pacini for her commitment to the board.
'The skills and dedication of our National Board of Directors are invaluable at a time when it's critical we bring affordable homeownership within reach for more families,' said Pedro Barata, Habitat Canada President & CEO. 'They represent a range of regional housing challenges and professional backgrounds, and bring knowledge and experience that help propel us forward as we deepen our impact in communities across Canada.'
For bios of the National Board of Directors, please visit: https://habitat.ca/en/about-us/our-team
About Habitat for Humanity Canada
Founded in 1985, Habitat for Humanity Canada is a national charitable organization that brings communities together to help families build strength, stability and independence through affordable homeownership. Habitat's unique national affordable homeownership program allows eligible families living with low-to-moderate income to purchase a home at fair market value with an affordable mortgage. With the generous support of donors and volunteers, and working with 45 local Habitats in every province and territory, we provide a solid foundation for better, healthier lives. Habitat for Humanity Canada is a member of Habitat for Humanity International, which was established in 1976 and has grown to become a leading global nonprofit working in more than 70 countries. For more information, please visit habitat.ca and follow on social @HabitatCanada.
For more information, please contact:Jennifer FowlerHabitat for Humanity Canada Director of CommunicationsJfowler@habitat.ca
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/75122c33-e356-4889-ac00-35f924163918
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
40 minutes ago
- Associated Press
Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer
CLEVELAND--(BUSINESS WIRE)--Aug 18, 2025-- Centerline Biomedical, Inc. ('Centerline'), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer (CEO) and a member of its board of directors. He will assume his responsibilities on August 18, 2025. Mr. Dillon succeeds Gulam Khan, who has served as CEO since October 2022. Mr. Khan led Centerline Biomedical through a period of portfolio development. During his tenure, Centerline Biomedical developed, received 510(k) clearance, and commercialized its second-generation devices and appreciable software advances. We appreciate Gulam's significant contributions. 'It is an honor to join Centerline at such a pivotal stage. The IOPS platform is poised for scaled growth and I am grateful to have the opportunity to lead the company as it continues to innovate such remarkable technology for patients and care givers,' said Mr. Dillon. 'With decades of med tech industry leadership, Jim brings deep cardiovascular sector experience leading portfolio innovation, operational alignment, and strategic financing for med tech companies,' said Todd Schwarzinger, Centerline's Chairman. 'Jim has a strong track record of driving commercial growth through category creation and market penetration and we are excited to have him leading Centerline.' Mr. Dillon has previously served as President and CEO for cardiovascular innovation companies; BiVACOR, BioVentrix, Reprieve Cardiovascular and Renal Guard Solutions. To learn more about the IOPS platform, visit About Centerline Biomedical Founded in 2015, Centerline Biomedical, Inc. is headquartered in Cleveland, Ohio. The company's commercially available platform, IOPS® (Intra-Operative Positioning System), enables improved visualization and device navigation, while protecting patient and healthcare provider exposure from the harmful effects of fluoroscopic X-ray radiation during standard interventions. The company is a Cleveland Clinic Innovations spin-off investing in commercialization and development of technology to improve image guidance and reduce the need for fluoroscopic x-ray during transcatheter procedures. IOPS is indicated for use in the peripheral, aortic and aortic side branch vasculature. The IOPS platform consists of a mobile cart powered by proprietary visualization software and intelligent, sensorized IOPS catheters and guidewires. Visit for more information. View source version on CONTACT: For inquiries, please contact: Patty Burns, SVP Marketing Centerline Biomedical, Inc. Email:[email protected] KEYWORD: UNITED STATES NORTH AMERICA OHIO INDUSTRY KEYWORD: CARDIOLOGY SOFTWARE RADIOLOGY HEALTH MEDICAL DEVICES HOSPITALS HEALTH TECHNOLOGY TECHNOLOGY SOURCE: Centerline Biomedical, Inc. Copyright Business Wire 2025. PUB: 08/18/2025 11:00 AM/DISC: 08/18/2025 11:00 AM
Business Wire
an hour ago
- Business Wire
Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer
CLEVELAND--(BUSINESS WIRE)--Centerline Biomedical, Inc. ('Centerline'), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer (CEO) and a member of its board of directors. He will assume his responsibilities on August 18, 2025. 'It is an honor to join Centerline at such a pivotal stage. The IOPS platform is poised for scaled growth and I am grateful to have the opportunity to lead the company as it continues to innovate such remarkable technology for patients and care givers.' Mr. Dillon succeeds Gulam Khan, who has served as CEO since October 2022. Mr. Khan led Centerline Biomedical through a period of portfolio development. During his tenure, Centerline Biomedical developed, received 510(k) clearance, and commercialized its second-generation devices and appreciable software advances. We appreciate Gulam's significant contributions. 'It is an honor to join Centerline at such a pivotal stage. The IOPS platform is poised for scaled growth and I am grateful to have the opportunity to lead the company as it continues to innovate such remarkable technology for patients and care givers,' said Mr. Dillon. 'With decades of med tech industry leadership, Jim brings deep cardiovascular sector experience leading portfolio innovation, operational alignment, and strategic financing for med tech companies,' said Todd Schwarzinger, Centerline's Chairman. 'Jim has a strong track record of driving commercial growth through category creation and market penetration and we are excited to have him leading Centerline.' Mr. Dillon has previously served as President and CEO for cardiovascular innovation companies; BiVACOR, BioVentrix, Reprieve Cardiovascular and Renal Guard Solutions. To learn more about the IOPS platform, visit About Centerline Biomedical Founded in 2015, Centerline Biomedical, Inc. is headquartered in Cleveland, Ohio. The company's commercially available platform, IOPS® (Intra-Operative Positioning System), enables improved visualization and device navigation, while protecting patient and healthcare provider exposure from the harmful effects of fluoroscopic X-ray radiation during standard interventions. The company is a Cleveland Clinic Innovations spin-off investing in commercialization and development of technology to improve image guidance and reduce the need for fluoroscopic x-ray during transcatheter procedures. IOPS is indicated for use in the peripheral, aortic and aortic side branch vasculature. The IOPS platform consists of a mobile cart powered by proprietary visualization software and intelligent, sensorized IOPS catheters and guidewires. Visit for more information.
Associated Press
6 hours ago
- Associated Press
Focus Graphite Announces Board Changes and Upcoming International Trade Mission with Natural Resources Canada
Susan Rohac, ICD.D, built one of Canada's largest and most active climate funds, overseeing a Pan-Canadian team of investment professionals and managed a portfolio over $1 billion in assets. Ottawa, Ontario--(Newsfile Corp. - August 18, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ('Focus' or the 'Company'), a leading Canadian graphite developer advancing high-grade projects in Québec, is pleased to announce the appointment of Mrs. Susan Rohac, ICD.D, to its Board of Directors, effective immediately. Mrs. Rohac replaces long-serving director Robin Dow, who has stepped down from the Board to focus on personal pursuits and other interests, and will continue to support a smooth transition. Susan Rohac had an extensive thirty-four (34) plus year career at the Business Development Bank of Canada ('BDC'), holding various leadership roles. Her final role was as Managing Partner of the Climate Tech venture capital fund, which she held from 2017 to May 2025. In this role, she oversaw a pan-Canadian team of investment professionals and managed a portfolio of over $1 billion in assets. This portfolio included a fully deployed $600 million fund I and a $500 million fund II launched in 2022 that focused on investing in Canada's most promising clean technology companies. Susan has invested in a diverse range of climate technologies across various sectors, including energy, mobility, built environment, carbon management, and industry & resource space, including advanced materials and critical minerals. In 2024, Susan was recognized as a Climate Leader by the Clean50 and received the Clean16 award. She holds undergraduate degrees in both science and finance and an executive MBA from the University of Ottawa. In 2024, she also obtained her ICD.D governance designation from the University of Toronto. Passionate about the environment and climate technologies, Susan currently sits on several governance and advisory boards and is actively involved with a few organizations that are aligned with her interests. 'We are delighted to welcome Susan to our Board,' said Jeff York, Founder and Chairman of Focus Graphite. 'She brings a strong track record in corporate finance and scaling industrial technologies, with a deep appreciation for Canada's critical minerals opportunity. Her experience and connections in the industry will be invaluable.' 'I am honored to join Focus Graphite at such an important moment,' said Ms. Rohac. 'The shift to green energy is driving unprecedented demand for secure supplies of critical minerals, and Canada has an opportunity to lead in building a reliable, sustainable graphite supply chain here at home. Beyond batteries, graphite is essential for advanced manufacturing and defense applications that underpin national security. I look forward to working with the team to help strengthen North America's self-sufficiency and reduce reliance on foreign supply.' Mr. York added, 'On behalf of the company and our shareholders, I want to thank Robin for his years of service and leadership. His guidance helped position Focus for its next phase of growth.' Focus Graphite is also pleased to announce its participation in the Canadian Critical Minerals Investment Forum, an international trade mission organized by Natural Resources Canada and Invest in Canada. The event will be held in Tokyo, Japan from August 26-28, 2025, and in Korea from August 29-30, 2025. Focus Graphite is one of only two Canadian graphite companies attending the Forum, which brings together global investors, government officials, and industry leaders to advance critical minerals partnerships. In addition to the Forum, the Company will hold a series of bilateral meetings in both countries to further strategic discussions with potential partners and customers. On August 14 th, 2025, Focus Graphite visited its Lac Knife project site near Fermont, Québec. The Company was pleased to host a representative from Korea Mine Rehabilitation and Mineral Resources Corporation ('KOMIR') alongside its newest board member, Susan Rohac. During the visit, Focus also met with officials from the Town of Fermont to provide a corporate and project update, highlighting recent progress and outlining the Company's pathway toward advancing Lac Knife to a fully permitted mining operation. In connection with Ms. Rohac's appointment, the Company has granted her 250,000 stock options pursuant to its Stock Option Plan. The options are exercisable at a price of $0.35 per common share and will expire on August 17, 2030. They are subject to the terms of the Plan as well as the policies of the TSX Venture Exchange. [ This image cannot be displayed. Please visit the source: ] Image 1: Focus Graphite executives, IOS Geosciences, and a representative from KOMIR visit the Lac Knife project near Fermont, Québec, August 14, 2025 To view an enhanced version of this graphic, please visit: [ This image cannot be displayed. Please visit the source: ] Image 2: Focus Graphite executives and IOS Geosciences visit with representatives from the Town of Fermont, QC, August 14, 2025 To view an enhanced version of this graphic, please visit: About Invest in Canada Invest in Canada is Canada's foreign direct investment (FDI) attraction and promotion agency. We find the best to invest in Canada. This means working with our partners across the country and worldwide to attract global companies and support their expansion plans in Canada. About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries. Our Lac Tétépisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining - we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency. Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals - reducing dependence on foreign-controlled markets and driving the transition to a sustainable future. For more information on Focus Graphite Inc. please visit Investors Contact: Dean Hanisch CEO, Focus Graphite Inc. Jason Latkowcer VP Corporate Development [email protected] Cautionary Note Regarding Forward-Looking Statements Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words 'could,' 'intend,' 'expect,' 'believe,' 'will,' 'projected,' 'estimated,' and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events. In particular, this press release contains forward-looking information regarding, among other things, the advancement of the Lac Knife project through permitting and development activities, the Company's participation in the Canadian Critical Minerals Investment Forum in Japan and Korea and the potential outcomes of related bilateral meetings, the anticipated benefits of Ms. Rohac's appointment to the Board of Directors, the Company's ability to establish strategic partnerships and secure future customers, and its positioning as a near- and long-term supplier of specialty graphite materials within North America and globally. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit
